For people 1 year of age and older with SHORT BOWEL SYNDROME (SBS) who are dependent on parenteral support (PS)
In a 6-month study of 86 adults, 63% of adults treated with GATTEX reduced their weekly volume of PS by 20% or more (vs 30% with placebo). 54% of adults treated with GATTEX achieved at least 1 day off of PS per week (vs 23% with placebo).
GATTEX reduced the weekly volume of parenteral support (PS).
People treated with GATTEX achieved more time off of parenteral support (PS).
Over time, some people achieved complete freedom from parenteral support (PS) with GATTEX.
In a 6-month study, 27 out of 43 adults treated with GATTEX reduced weekly PS volume by 20% or more vs 13 out of 43 on placebo, and 21 out of 39 achieved at least 1 day off PS per week vs 9 out of 39 on placebo. After 30 months of treatment, 10 out of 30 adults no longer needed PS. In a 6-month study, 18 out of 26 children treated with GATTEX reduced weekly PS volume by 20% or more, 10 out of 26 achieved a reduction of at least 1 day off PS per week, and 3 out of 26 no longer needed PS.
Examples of how some patients may spend their time with reduced PS requirements are for illustrative purposes only. Be sure to discuss your medical circumstances and activities with your doctor.
SBS is a serious and chronic malabsorption disorder.Learn About SBS
Download our helpful Conversation Guide or see what goes into getting started.Getting started
Connect with others, download resources, and learn about our patient support program.Access resources
Sign up to receive ongoing updates and communications about upcoming events, treatment information, education, resources, and market research opportunities.
Please see our online privacy notice for information about our practices regarding collection, use, and disclosure of information that you may provide us.
What is GATTEX?
GATTEX® (teduglutide) for subcutaneous injection is a prescription medicine used in adults and children 1 year of age and older with Short Bowel Syndrome (SBS) who need additional nutrition or fluids from intravenous (IV) feeding (parenteral support). It is not known if GATTEX is safe and effective in children under 1 year of age.
Important Safety Information
GATTEX may cause serious side effects, including making abnormal cells grow faster, polyps in the colon (large intestine), blockage of the bowel (intestines), swelling (inflammation) or blockage of your gallbladder or pancreas, and fluid overload. Click here for additional Important Safety Information.
Thank you! Please click the button below to download results or see the results here.
You are about to leave this site. Click “Yes” to continue.I want to stay Yes